FR1604537A - Vaccine for cattle - Google Patents
Vaccine for cattleInfo
- Publication number
- FR1604537A FR1604537A FR1604537DA FR1604537A FR 1604537 A FR1604537 A FR 1604537A FR 1604537D A FR1604537D A FR 1604537DA FR 1604537 A FR1604537 A FR 1604537A
- Authority
- FR
- France
- Prior art keywords
- mixtures
- agent
- added
- inactivating
- myxovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
- C12N2760/18634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Process for preparing vaccines against shipping fever in cattle by inactivating virus- and bacteria cultures with an inactivating agent. To cultures of Myxovirus parainfluenza-3 or mixtures of this with Pasteurella multocida and/or Past. haemolytica, an aluminium ion-containing agent is added having an Al-content equivalent to 10-50 ml of a 1.3% Al2O3 dispersion in water/ 100 ml culture. The agent is added before- or after combination of the 3 organisms to form one or more mixtures. The mixtures must have an optical density of 5-10 times the optical density of tube 1 on the McFarland scale, whereby the Myxovirus parainfluenza-3 and Pasteurella organisms are inactivated before or after forming the final mixture by treatment with an inactivating agent, followed by neutralisation of any excess. A parenterally acceptable antiseptic in bacteriostatic- and fungistatic amounts is then added.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR121186 | 1967-09-15 |
Publications (1)
Publication Number | Publication Date |
---|---|
FR1604537A true FR1604537A (en) | 1971-11-29 |
Family
ID=8638423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1604537D Expired FR1604537A (en) | 1967-09-15 | 1967-09-15 | Vaccine for cattle |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR1604537A (en) |
-
1967
- 1967-09-15 FR FR1604537D patent/FR1604537A/en not_active Expired
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CH407071A (en) | Process for the production of ethyl alcohol | |
AT260520B (en) | Process for the production of an ethylene copolymer | |
AT303385B (en) | Process for the preparation of aqueous dispersions | |
AT274349B (en) | Process for the preparation of aqueous solutions containing high molecular weight polyacrylamide and sodium polyacrylate | |
FR1604537A (en) | Vaccine for cattle | |
FR1604109A (en) | Live attenuated rabies vaccine is produced by culturing the virus in chick embryo tissue contng. 0.5-5% of a hydrolysed collagen deriv., such as gelatin, which | |
CH480434A (en) | Process for the preparation of the antibiotic kasugamycin | |
AT255659B (en) | Process for the preparation of sterile, non-toxic aerosol solutions | |
CH489470A (en) | Process for the production of L-ornithine by fermentation | |
CH521334A (en) | Process for the preparation of curable cycloaliphatic glycidyl ethers | |
CH466894A (en) | Process for the preparation of a vaccine against infectious gastroenteritis | |
AT247287B (en) | Process for the preparation of a salt mixture rich in potassium peroxomonosulfate | |
DE2135246B2 (en) | METHOD FOR PRODUCING L-TYROSINE BY MICROBIOLOGICAL WAYS | |
AT273952B (en) | Process for the preparation of 1- (2'-hydroxyethyl) -2-carbamoyl-5-nitropyrrole | |
GB1201052A (en) | Vaccines | |
CH460503A (en) | Process for the production of a bacterial preparation | |
CH535281A (en) | Process for preparing a non-anaphylactic PPAO vaccine | |
AT259527B (en) | Process for the preparation of dispersions | |
AT279038B (en) | Process for the preparation of a vaccine against rubella | |
CH515991A (en) | Process for the preparation of the antibiotic tsushimycin | |
CH415674A (en) | Process for the preparation of derivatives of 3-phenyl-7-oxychromone | |
GB949400A (en) | Poliomyelitis vaccines | |
AT314832B (en) | Process for the preparation of a hydroxy ether | |
AT232282B (en) | Process for the production of high molecular weight polyoxymethylenes | |
FR1180507A (en) | Advanced process for sterilizing water with ozonated air |